Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|March 3, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal SyndromeFlorence Wong, S Chris Pappas, Michael P Curry, et al.
Hepatology Communications|May 23, 2025
Parental liver disease mortality is associated with unfavorable outcomes in patients with alcohol-associated hepatitisWanzhu Tu, Samer Gawrieh, Lauren Nephew, et al.
Hepatology (Baltimore, Md.)|November 28, 2019
An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated HepatitisJuan P Arab, Tejasav S Sehrawat, Douglas A Simonetto, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomesJoseph C Ahn, Puru Rattan, Patrick Starlinger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2024
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant populationK Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 2025
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver diseaseVictoria E Kusztos, Tiffany Wu, Blake Kassmeyer, et al.
Mayo Clinic Proceedings|July 7, 2018
Clinical Correlates and Treatment Outcomes for Patients With Short Telomere SyndromesAbhishek A Mangaonkar, Alejandro Ferrer, Filippo Pinto E Vairo, et al.
Hepatology Communications|April 1, 2026
The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practicesGiuseppe Cullaro, Gene Y Im, Shaun Chandna, et al.
Clinical and Translational Gastroenterology|May 12, 2021
Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective StudyAndrew S Allegretti, Xavier Vela Parada, Paul Endres, et al.
Pageof 14